Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether trastuzumab and letrozole are effective and
safe in the preoperative treatment for postmenopausal patients with hormone receptor-positive
and HER2-positive breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Gangnam Severance Hospital
Collaborators:
Asan Medical Center Samsung Medical Center Seoul National University Hospital Severance Hospital